Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONQUER SCD Pain Trial
NCT06635902Phase 2Recruiting
- Start
- Dec 2024
- Primary completion
- Jun 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of citrulline in sickle cell disease (SCD) (3 arms). Primary endpoint: Time-to-crisis resolution at 30 days. Started Dec 2024; status: recruiting.
02
Drugs
citrulline
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT06635902.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06635902.